Monday, July 13, 2015
Mike had another CEA test done on July 8th following his visit to the Emergency Room. This showed his level to now be at 4635.8 which has increased since the last time this was done. Mike return to the cancer center for reassessment. The doctor stated he was showing scleral icterus which is when the normally white area (sclera) of the eye is yellow because the patient has jaundice, and he had dark urine. He was also experiencing itching over his body and was complaining of right upper quadrant pain.
Due to this, Mike has decided to reinitiate chemotherapy. Because of Mike's mild jaundice and his bilirubin of 3, the doctor decided to reduce the chemotherapy by 25-30%. He was started on cycle #1 of palliative FOLFIRI plus Avastin. He was advised to take his Phenergan every 6 hours a needed for nausea.
The doctor told Mike that his prognosis was extremely poor, and the chemotherapy was palliative once again. He also said that if this was ineffective or if he developed complications, he would likely require hospice treatment. He is to follow up in 2 weeks for reassessment. We will wait to see how he responds to this.
Monday, July 27, 2015
Cycle #2. The doctor noted that Mike's jaundice and itching has improved. He stated, clinically, he had a response to cycle #1 of this chemotherapy. Therefore, he recommended that Mike continue with cycle #2 at the same dosing. He is to return in 2 weeks for cycle #3.
Monday, August 10, 2015
Mike returned for cycle #3 of the FOLFIRI plus Avastin. Mike denied any fever or chills or pain. He was experiencing some mild nausea from the treatment which was expected.
Since Mike was responding to this treatment, it was decided that Mike would proceed with cycle #3 of the FOLFIRI plus bevacizumab at a reduced dose,
Mike was advised to continue his routine medications and activity. He was advised to avoid direct sun exposure. The doctor stated his liver enzymes were improving. He is to return in 2 weeks for cycle #4.
Monday, August 24, 2016
Cycle #4. Per doctor, Mike is responding nicely, He stated Mike had no significant toxicity and was adequately palliated. Return in 2 weeks for cycle #5.
Mike had another CEA test done on July 8th following his visit to the Emergency Room. This showed his level to now be at 4635.8 which has increased since the last time this was done. Mike return to the cancer center for reassessment. The doctor stated he was showing scleral icterus which is when the normally white area (sclera) of the eye is yellow because the patient has jaundice, and he had dark urine. He was also experiencing itching over his body and was complaining of right upper quadrant pain.
Due to this, Mike has decided to reinitiate chemotherapy. Because of Mike's mild jaundice and his bilirubin of 3, the doctor decided to reduce the chemotherapy by 25-30%. He was started on cycle #1 of palliative FOLFIRI plus Avastin. He was advised to take his Phenergan every 6 hours a needed for nausea.
The doctor told Mike that his prognosis was extremely poor, and the chemotherapy was palliative once again. He also said that if this was ineffective or if he developed complications, he would likely require hospice treatment. He is to follow up in 2 weeks for reassessment. We will wait to see how he responds to this.
Monday, July 27, 2015
Cycle #2. The doctor noted that Mike's jaundice and itching has improved. He stated, clinically, he had a response to cycle #1 of this chemotherapy. Therefore, he recommended that Mike continue with cycle #2 at the same dosing. He is to return in 2 weeks for cycle #3.
Monday, August 10, 2015
Mike returned for cycle #3 of the FOLFIRI plus Avastin. Mike denied any fever or chills or pain. He was experiencing some mild nausea from the treatment which was expected.
Since Mike was responding to this treatment, it was decided that Mike would proceed with cycle #3 of the FOLFIRI plus bevacizumab at a reduced dose,
Mike was advised to continue his routine medications and activity. He was advised to avoid direct sun exposure. The doctor stated his liver enzymes were improving. He is to return in 2 weeks for cycle #4.
Monday, August 24, 2016
Cycle #4. Per doctor, Mike is responding nicely, He stated Mike had no significant toxicity and was adequately palliated. Return in 2 weeks for cycle #5.
